Connect with us

Technology

Waterdrop Q4 and FY2024 Financial Results: Annual Net profit rises 119.8% YoY, and declared a cash dividend

Published

on

BEIJING, March 12, 2025 /PRNewswire/ — On March 12, 2025, Waterdrop Inc. (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare services with a positive social impact, unveiled its unaudited financial results for the fourth quarter and Fiscal Year ended December 31, 2024.

During the fourth quarter, Waterdrop reported net operating revenue of RMB 686.8 million. Net profit attributable to ordinary shareholders totaled RMB 99.6 million, up 68.5% from the same quarter of previous year, sustaining profitability for the twelfth consecutive quarter. Operating expenses, including sales and marketing expenses, general and administrative expenses, research and development expenses, accounted for 45.1% of revenue.

For the year of 2024, Waterdrop reported net operating revenue increased by 5.4% year over year to RMB 2,771.8 million. Net profit attributable to ordinary shareholders totaled RMB 367.5 million, up 119.8% from the previous year. Operating expenses, including sales and marketing expenses, general and administrative expenses, research and development expenses, accounted for 46.1% of revenue, a decrease of 8.7 percentage points year-on-year.

In recognition of the invaluable support from shareholders, Waterdrop declared another cash dividend. The cash dividend of US$0.02 per ADS or US$0.002 per ordinary share, to shareholders of record as of the close of business on April 11, 2025. The payment date is expected to be on or around April 30, 2025 for holders of ordinary shares and on or around May 2, 2025 for holders of ADSs.

Since announcing its first share repurchase program in September 2021, as of February 28, 2025, Waterdrop has repurchased approximately 52.1 million American Depositary Shares (ADSs) from the open market with cash for a total consideration of approximately US$103.7 million.

As of December 31, 2024, cash position of the Company was RMB3,670.3 million (US$502.8 million), as compared with RMB3,571.6 million as of December 31, 2023.

Insurance Business Operating Profit Totaled RMB 477.2 Million in 2024

In the fourth quarter of 2024, Waterdrop’s insurance-related revenue amounted to RMB 582.4 million. The first-year premiums (“FYP”) generated through the insurance business amounted to RMB1,897.9 million, representing an increase of 24.5% year over year. For the year of 2024, Waterdrop’s insurance-related income amounted to RMB2,363.8 million.  Annual operating profit totaled RMB 477.2 million.

Mr. Peng Shen, Founder, Chairman, and Chief Executive Officer of Waterdrop, commented, “Our insurance business capped off the year with an annual FYP of RMB7,472.8 million, marking a 5.1% year-over-year growth. Throughout the fourth quarter, we honed our focus on optimizing customer acquisition channels and diversifying product offerings, which yielded robust outcomes. Our targeted acquisition strategies spurred a 14.9% year-over-year surge in new user acquired.”

Waterdrop recently announced the strategic integration and local deployment of DeepSeek models, which marks a significant step forward in the AI-driven insurance ecosystem. Utilizing advanced AI models, Waterdrop’s AI Insurance Expert now supports multi-modal interactions, including voice and text. The system excels in managing complex dialogues and assisting with sales strategies, autonomously handling voice communications and consultations for medical insurance products.

Waterdrop Medical Crowdfunding Raised RMB 67.5 Billion for 3.40 Million Patients

During the quarter, Waterdrop Medical Crowdfunding upheld its mission of “emergency rescue” with remarkable success. As of December 31, 2024, around 470 million people cumulatively had donated an aggregate of RMB 67.5 billion to 3.40 million patients through Waterdrop Medical Crowdfunding.

As a milestone, Waterdrop Medical Crowdfunding has been officially recognized as a pioneer in China’s standardized medical crowdfunding sector. Following new legislation changes, the platform secured designation from the Ministry of Civil Affairs on December 25, 2024, becoming one of the first batch of state-endorsed “Online Service Platforms for Individuals Seeking Financial Help”.

Waterdrop’s Digital Clinical Trial Solution has maintained its growth in the fourth quarter of 2024, generating revenues of approximately RMB 25.5 million, representing an increase of 22.9% YoY. And the income amounted to RMB91.1 million in 2024. As of December 31, 2024, the Company had cumulatively enrolled 10,395 patients into 1,212 clinical trial programs through the E-Find Platform.

Mr. Peng Shen, said, “In 2024, Waterdrop delivered solid performance across all business units, driven by its integrated scenario ecosystem and sustained AI investments. By fully upgrading products and services through these strategic advantages, the company has established new benchmarks for Al implementation in the industry. Amid accelerating technologies advance in 2025, Waterdrop remains committed to “Tech for Good”, strategically leveraging resilience to capture emerging opportunities while fostering inclusive growth through accessible AI solutions.”

Waterdrop Announces Appointment of New Independent Director

Waterdrop today announced the appointment of Mr. Chen Lin as an independent director and a member of the audit committee of the Company’s board of directors, effective March 11, 2025.

Mr. Chen Lin has served at various positions at The University of Hong Kong, including as the Chair of Finance and Stelux Professor in Finance since August 2013, and Associate Vice President since January 2023. In addition, Mr. Lin has served as an independent non-executive director for several companies, including Artificial Intelligent Interconnection Technology Co., Ltd. since December 2024, Beijing 51WORLD Digital Twin Technology Co., Ltd. since September 2024, Shiyue Daotian Group Co., Limited (HKEX: 09676) since October 2023, Allianz Global Investors Fund Management Co., Ltd. since September 2023, CNCB (Hong Kong) Investment Limited since January 2022, and China Merchants Land Asset Management Co., Limited (the manager of China Merchants Commercial REIT (HKEX: 01503)) since December 2019.

Mr. Lin is a non-official member of the Task Force on Promoting Web3 Development of the Government of Hong Kong since July 2023, a Fellow of the Academy of Social Sciences, UK since March 2023, a Member of the Academia Europaea since June 2022, a member of the Hang Seng Index Advisory Committee since August 2021, a member of the Fintech Advisory Group of the Securities and Futures Commission since March 2021 and an advisory member of the Hong Kong Institute for Monetary and Financial Research of the Hong Kong Monetary Authority since June 2019. Mr. Lin also served as a member of the Currency Board Sub-Committee of the Exchange Fund Advisory Committee of Hong Kong from January 2017 to December 2022.

Mr. Lin obtained his PhD degree in economics in August 2006, master of arts degree in economics in August 2005 and master of business administration degree (MBA) in May 2004 from University of Florida in the United States. He received his bachelor’s degree in engineering from South China University of Technology in July 2000.

 

View original content:https://www.prnewswire.com/apac/news-releases/waterdrop-q4-and-fy2024-financial-results-annual-net-profit-rises-119-8-yoy-and-declared-a-cash-dividend-302399752.html

SOURCE Waterdrop Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

QUAD GmbH Expands Its Technology Offerings and Relationship with Vuzix with Follow-on Six-figure Smart Glasses Order

Published

on

By

ROCHESTER, N.Y., March 19, 2025 /PRNewswire/ — Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of AI-powered Smart glasses, waveguides and Augmented Reality (AR) technologies, today announced that the Company has received and shipped against a follow-on six-figure smart glasses order from QUAD GmbH (“QUAD”), a leading distributor and consulting company in the areas of Auto-ID, Transport, Logistics and OEM Integration. QUAD’s newly formed QUAD Advanced Systems division provides full scale services and support for Vuzix products to its customers throughout Europe, focusing on the field service, manufacturing, security, warehouse and logistics and healthcare market verticals.

QUAD Advanced Systems, which consolidates its previous auto ID, transport, logistics and OEM divisions under one roof, will provide comprehensive support throughout the product lifecycle. Their deep technical knowledge of Vuzix smart glasses extends to real-world applications, including remote monitoring and operations assistance, warehousing logistics, and medical field innovations, where AR technology enhances operational precision and efficiency. QUAD’s expertise enables tailored solutions, such as optimizing smart glasses for inventory management, remote expert collaboration, or surgical support. To accelerate decision-making, QUAD facilitates rapid online demos, allowing clients to experience Vuzix technology virtually, followed by personalized guidance to connect with the best-fit reseller for their industry-specific needs.

“QUAD prides itself in investing in the future, and partnering with Vuzix ensures that we continue that tradition of providing truly state-of-the-art solutions for our customers,” said Andreas Wey, CEO of QUAD GmbH. “Operational efficiency is a real differentiator, and nothing encapsulates that more than the use of AR technology enabled through the use of smart glasses. We are absolutely delighted to both offer and support the Vuzix product range across our core vertical markets.”

“We are excited to be expanding our relationship with QUAD, who has built a strong reputation as a premier European distributor of technology and consulting services over the past 30 years,” said Paul Travers, President and CEO of Vuzix. “QUAD’s hands-on approach in sectors like healthcare and warehousing, combined with its ability to troubleshoot real-time challenges, underscores its role as a valued Vuzix partner.”

About Vuzix Corporation

Vuzix is a leading designer, manufacturer and marketer of AI-powered Smart Glasses, Waveguides and Augmented Reality (AR) technologies, components and products for the enterprise, medical, defense and consumer markets. The Company’s products include head-mounted smart personal display and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays and augmented reality, as well OEM waveguide optical components and display engines. Vuzix holds more than 425 patents and patents pending and numerous IP licenses in the fields of optics, head-mounted displays, and the augmented reality wearables field. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2024 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in: Rochester, NY; and Kyoto and Okayama, Japan. For more information, visit the Vuzix website, Twitter and Facebook pages.

Forward-Looking Statements Disclaimer

Certain statements contained in this news release are “forward-looking statements” within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Forward looking statements contained in this release relate to Vuzix Smart Glasses, our business relationship and future opportunities with QUAD GmbH and its customers, and among other things the Company’s leadership in the Smart Glasses and AR display industry. They are generally identified by words such as “believes,” “may,” “expects,” “anticipates,” “should” and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company’s beliefs and assumptions as of the date of this release. The Company’s actual results could differ materially due to risk factors and other items described in more detail in the “Risk Factors” section of the Company’s Annual Reports and MD&A filed with the United States Securities and Exchange Commission and applicable Canadian securities regulators (copies of which may be obtained at www.sedar.com or www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.

Vuzix Media and Investor Relations Contact:

Ed McGregor, Director of Investor Relations,
Vuzix Corporation
ed_mcgregor@vuzix.com  
Tel: (585) 359-5985

Vuzix Corporation, 25 Hendrix Road, West Henrietta, NY 14586 USA,
Investor Information – IR@vuzix.com  www.vuzix.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/quad-gmbh-expands-its-technology-offerings-and-relationship-with-vuzix-with-follow-on-six-figure-smart-glasses-order-302405786.html

SOURCE Vuzix Corporation

Continue Reading

Technology

China-Austria Economic and Trade Cooperation Forum and 3rd CISCE Promotion Held in Vienna

Published

on

By

VIENNA, March 19, 2025 /PRNewswire/ — The China-Austria Economic and Trade Cooperation Forum, in conjunction with a promotional event for the third China International Supply Chain Expo (“CISCE”), was held in Vienna, Austria. The gathering brought together over 200 representatives from trade and investment promotion agencies, business associations, and companies from both China and Austria. During the forum, China International Exhibition Center Group spotlighted the upcoming CISCE and inked cooperation agreements with key Austrian institutions and businesses.

Ren Hongbin, chairman of the China Council for the Promotion of International Trade (“CCPIT”), praised the recent progress in Sino-Austrian collaboration across multiple sectors. He highlighted China’s readiness to work closely with Austrian partners to leverage complementary strengths in resources and industrial frameworks. Ren also encouraged businesses from both nations to explore new opportunities for business expansion and invited Austrian businesses and institutions to participate in the 3rd CISCE.

The event was attended by Christoph Matznetter, Vice President of the Austrian Federal Economic Chamber, and Qi Mei, the Chinese Ambassador to Austria, among other prominent guests.

Austrian representative, noted that the forum represented the first significant economic and trade event between Austria and China since the inauguration of the new Austrian government, underscoring its crucial role in strengthening bilateral relations. He affirmed China as a reliable partner and lauded the CISCE as a leading exhibition dedicated to enhancing international industrial and supply chain cooperation. He also expressed optimism about broader cooperation to address global challenges and uphold international trade norms.

The China International Supply Chain Expo, recognized as the world’s premier national-level exhibition focused on supply chains, aims to facilitate integration across upstream, midstream, and downstream sectors, connect businesses of all sizes, encourage collaboration between industry, academia and research institutions, while enhancing interaction between Chinese and multinational businesses. Under the theme Connecting the World for a Shared Future, it has emerged as a crucial platform for bolstering international cooperation in industrial and supply chains. The 3rd CISCE will be held from July 16th to 20th in Beijing, with exhibition zones featuring Advanced Manufacturing, Clean Energy, Smart Vehicle and more, with over 300 companies already confirming their participation.

Earlier this year, the promotional events for CISCE were held in Germany, Switzerland, Portugal, and the UK to reinforce cooperative ties between China and European nations, broadening and deepening bilateral economic and trade relations.

Photo – https://mma.prnewswire.com/media/2645319/photo.jpg
Logo – https://mma.prnewswire.com/media/2427202/CISCE_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/china-austria-economic-and-trade-cooperation-forum-and-3rd-cisce-promotion-held-in-vienna-302405881.html

Continue Reading

Technology

Alamar Biosciences Announces First Five Distribution Partners, Expanding Commercial Support in Asia Pacific

Published

on

By

FREMONT, Calif., March 19, 2025 /PRNewswire/ — Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce the signing of five new distribution partners to expand its global presence. The company has partnered with established industry leaders across key international markets to enhance access to its innovative proteomics technologies.

The newly signed distribution partners include:

GeneWorksAustralia and New ZealandGenomaxSingaporePhileKoreaSouth KoreaScrum Inc.JapanSpincoIndia

“We are excited to welcome these outstanding partners to the Alamar network,” said Yuling Luo, Ph.D., Founder, Chairman and CEO of Alamar Biosciences, “Their deep expertise in the life sciences industry and strong regional presence will allow us to bring our next-generation proteomics solutions to more researchers and clinicians worldwide.”

Alamar’s technology empowers scientists to achieve groundbreaking insights in biomarker discovery, drug development, and disease research. Through these new partnerships, researchers in Asia-Pacific will now have enhanced access to Alamar’s cutting-edge platforms and technical support.

Alamar remains committed to supporting the scientific community with best-in-class tools that enable high-sensitivity protein analysis. For more information on Alamar’s distribution network and solutions, visit alamarbio.com.

About Alamar Biosciences, Inc.

Alamar Biosciences is a privately held life sciences company with a mission to power precision proteomics to enable the earliest detection of disease. The company’s proprietary NULISA™ Platform along with the ARGO™ HT System work seamlessly with the latest advances in genomics to achieve single digit attomolar detection sensitivity, greatly surpassing the most sensitive protein detection technology on the market today. For more information, please visit alamarbio.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/alamar-biosciences-announces-first-five-distribution-partners-expanding-commercial-support-in-asia-pacific-302405723.html

SOURCE Alamar Biosciences, Inc.

Continue Reading

Trending